Ticker Details
Relmada Therapeutics, Inc.
IPO Date:	June 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$738.43M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 3.85%
Avg Daily Range (30 D):	$0.22 | 3.01%
Avg Daily Range (90 D):	$0.19 | 3.51%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	1.11M
Avg Daily Volume (90 D):	1.39M

Trade Size
Avg Trade Size (Sh.):	137
Avg Trade Size (Sh.) (30 D):	86
Avg Trade Size (Sh.) (90 D):	96

Institutional Trades
Total Institutional Trades:	408
Avg Institutional Trade:	$2.1M
Avg Institutional Trade (30 D):	$.78M
Avg Institutional Trade (90 D):	$1.22M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.24M
Avg Closing Trade (30 D):	$1.01M
Avg Closing Trade (90 D):	$1.6M
Avg Closing Volume:	133.71K

News

May 5, 2026 @ 11:00 AM Relmada Therapeutics to Present NDV-01 Abstracts a... Source: Na

Mar 12, 2026 @ 11:00 AM Relmada Therapeutics to Report Fourth Quarter 2025... Source: Na

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Jul 31, 2025 @ 11:00 AM Relmada Therapeutics to Report Second Quarter 2025... Source: Corporate Communications

Apr 28, 2025 @ 5:38 PM Relmada Therapeutics Presents Positive Initial Pha... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.11	$-.22	$-.29
Diluted EPS	$-1.11	$-.22	$-.29
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-58.88M	$-19.05M	$-19.87M
Operating Income / Loss	$-60.34M	$-19.46M	$-20.33M
Cost of Revenue
Net Cash Flow	$5.92M	$6.28M	$2.11M
PE Ratio

Splits
Sep 30, 2019	1:4
Aug 12, 2015	1:5